32.70USD-2.39%Mkt Cap: 1.68B USDP/E: 76.28Last update: 2026-06-01
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.68B USD
Enterprise Value1.65B USD
Revenue (TTM)292.09M USD
Gross Profit205.60M USD
Net Income (TTM)16.52M USD
Revenue/Share5.777 USD
Last Price32.70 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees398
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS92346J1088
Valuation
P/E (Trailing)76.28
P/E (Forward)39.12
PEG—
EV/EBITDA59.19
EV/Revenue5.65
P/S5.83
P/B4.77
EPS (TTM)0.43
EPS (Forward)0.85
52W Range
28.9522% of range45.97
52W High45.97 USD
52W Low28.95 USD
Profitability
Gross Margin74.42%
Oper. Margin-11.79%
EBITDA Margin9.55%
Profit Margin5.98%
ROE4.66%
ROA3.39%
Growth
Revenue Growth30.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF51.91M USD
CapEx (TTM)27.16M USD
FCF Margin14.51%
FCF Yield2.53%
Net Debt-50.30M USD
Net Debt/EBITDA-1.80
Balance Sheet
Debt/Equity0.27
Current Ratio5.18
Quick Ratio4.62
Book Value/Sh6.984 USD
Cash/Share2.846 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateOct 16, 2013
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)55.43 USD
Target Range42.00 USD – 70.00 USD
# Analysts7
Ownership
Shares Out.51.07M
Float50.43M
Insiders1.20%
Institutions111.21%
Short Interest
Short Ratio8.4d
Short % Float13.47%
Short % Out.10.45%
Shares Short5.34M
Short (prev mo.)5.08M
Technical
SMA 5033.98 (-3.8%)
SMA 20035.38 (-7.6%)
Beta1.16
S&P 52W Chg27.70%
Avg Vol (30d)574.70K
Avg Vol (10d)542.01K
Technical Indicators
RSI (14)45.0
MACD-0.0438
MACD Signal0.0182
MACD Hist.-0.0620
BB Upper37.14 USD
BB Middle34.55 USD
BB Lower31.96 USD
BB Width14.99%
ATR (14)1.594 USD
Vol Ratio (20d)0.28x